Literature DB >> 1847975

Prospects for the treatment of multiple sclerosis.

R A Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1847975      PMCID： PMC1293085          DOI： 10.1177/014107689108400201

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  22 in total

1.  Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

Authors:  J H Noseworthy; M K Vandervoort; C J Wong; G C Ebers
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

2.  Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.

Authors:  A J Thompson; C Kennard; M Swash; B Summers; G M Yuill; D I Shepherd; S Roche; G D Perkin; L A Loizou; R Ferner
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

3.  The trials of clinical trials.

Authors:  G M McKhann
Journal:  Arch Neurol       Date:  1989-06

4.  A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota.

Authors:  D R Wynn; M Rodriguez; W M O'Fallon; L T Kurland
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

5.  Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.

Authors:  J P Soulillou; D Cantarovich; B Le Mauff; M Giral; N Robillard; M Hourmant; M Hirn; Y Jacques
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

6.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

Authors:  L J Kinlen
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

7.  Scales for rating impairment in multiple sclerosis: a critique.

Authors:  E W Willoughby; D W Paty
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

Authors:  I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

9.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Authors:  N M Milligan; R Newcombe; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

10.  Intrathecal baclofen for severe spinal spasticity.

Authors:  R D Penn; S M Savoy; D Corcos; M Latash; G Gottlieb; B Parke; J S Kroin
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245
View more
  1 in total

1.  Pathogenesis of multiple sclerosis.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.